Labshake search
Citations for R&D Systems :
401 - 450 of 1050 citations for tert Butyl 5 methoxypyridine 3 4 diyl bis methylene dicarbamate since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2023Quote: ... Concentration of sCTLA-4 was estimated by ELISA (R&D Systems, DY476) or SDS-PAGE/CBB staining with bovine serum albumin (BSA ...
-
CRISPR-Cas9 Engineered Extracellular Vesicles for the Treatment of Dominant Progressive Hearing LossbioRxiv - Bioengineering 2023Quote: ... specimens were stained with anti-4 hydroxynonenal (R&D Systems MSB 3249) or anti 3-nitrotyrosine ...
-
bioRxiv - Neuroscience 2023Quote: ... or anti-toll-like receptor 4 (TLR4; clone #610029, R&D Systems). All antibodies were titrated using negative control cells that don’t or poorly express the target protein ...
-
bioRxiv - Cell Biology 2022Quote: ... and Laminin (R&D Systems #3446-005-01, 4-8 µg/cm2) coated glass-bottom Petri dishes (Greiner Bio-One #627975 ...
-
bioRxiv - Immunology 2024Quote: ... 4) IL1B/IL1F2 DuoSet ELISA kits (R&D Systems, Minneapolis, MN, USA), following manufacturer’s protocols ...
-
bioRxiv - Immunology 2024Quote: ... anti- IL-4 and 2 ng/ml rhTGF-β1 (R&D Systems).
-
bioRxiv - Cancer Biology 2024Quote: ... The ligands used were His-Tagged human Nectin-4 (R&D systems, catalog # 2659-N4-050 ...
-
bioRxiv - Cell Biology 2024Quote: ... 4 µl of recombinant human VEGF (1 µg/µl, R&D Systems), or 4 µl of a solution containing both FITC-traC (0.75 µg/µl ...
-
bioRxiv - Developmental Biology 2020Quote: ... mouse anti-Nkx2-5 (25 μg/ml, R&D Systems, #259416), rabbit anti-MYL7 (1:1000 ...
-
bioRxiv - Molecular Biology 2022Quote: ... mice were treated with 5 µg RSPO3 (R&D systems #4120RS025CF) in 100 µL PBS 18 ...
-
bioRxiv - Neuroscience 2020Quote: ... SCH 23390 hydrochloride (5 μM; R&D Systems, Minneapolis, MN, USA) was added to the aCSF ...
-
bioRxiv - Immunology 2021Quote: ... and recombinant human IL-1β (5 units/mL; R&D Systems) in the presence or absence of PAD2/PAD4 inhibitor (5 μM YW3-56 ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 ng/mL HB-EGF (R&D Systems, 259-HE-050), 10 ng/mL CNTF (R&D Systems ...
-
bioRxiv - Cancer Biology 2020Quote: ... and 5 ng/ml recombinant human TGF-β (R&D Systems). After 72 h ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 5% fetal bovine serum (FBS, R&D SYSTEMS, S11150) and 1% penicillin/streptomycin (P/S ...
-
bioRxiv - Immunology 2020Quote: ... and 5 μg of anti-ACE2 antibody (R&D systems, AF933) or isotope control IgG (R&D systems ...
-
bioRxiv - Neuroscience 2023Quote: ... Membranes were blocked in 5% nonfat skim milk (R&D Systems) for 1 h at room temperature ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 5 ng/ml BMP4 (R&D Systems, 314-BP), 50 ng/ml VEGF (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 5% fetal bovine serum (R&D systems; cat# S11150), 0.4 μg/ml hydrocortisone (Sigma ...
-
bioRxiv - Cancer Biology 2024Quote: ... and recombinant human IL-7 (5 ng/mL) (R&D Systems).
-
bioRxiv - Biochemistry 2023Quote: ... (v) 5 µg/ml human DC-SIGN-Fc (R&D System), 5 µg/ml human MGL-Fc (R&D System ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 ng/mL HB-EGF (R&D Systems 259-HE-050), and 20 ng/mL FGF-2 (R&D Systems ...
-
bioRxiv - Immunology 2024Quote: ... and 5 µg/ml anti-GM-CSF (MP122E9, R&D Systems) or 1 µg/ml anti-PECAM-1 (MEC13.3 ...
-
bioRxiv - Developmental Biology 2024Quote: ... media was replaced with 5 ng/ml FGF2 (R&D Systems), 15 ng/ml VEGF (Peprotech) ...
-
bioRxiv - Genetics 2024Quote: ... and 5 ng/ml recombinant human IL-15 (R&D Systems). After two days of activation ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 ng/mL HB-EGF (R&D Systems, 259-HE-050), 1X B27 supplement (Gibco ...
-
bioRxiv - Developmental Biology 2024Quote: ... 10 ng/mL GDF-5 (R&D Systems, Minneapolis, MN, USA), and 0.05 mM L-ascorbic acid 2-phosphate ...
-
bioRxiv - Molecular Biology 2021Quote: ... in the presence of IL-3 (1 ng/mL, R&D Systems, Minneapolis, MN, USA) at 37°C and 5% CO2 ...
-
bioRxiv - Microbiology 2020Quote: ... phosphorylated CREB (pCREB) and cleaved caspase-3 were measured using ELISA kits (R&D Systems) according to the manufacturer’s instructions.
-
bioRxiv - Cancer Biology 2022Quote: ... and human FMS like tyrosine kinase 3 ligand (FLT3L, 100 ng/mL, R&D Systems).
-
bioRxiv - Physiology 2020Quote: ... 3-day-old pups were intraperitoneally injected with sterile murine rIGF-1 (R&D systems) or sterile PBS daily at a dose of 200μg/kg until weaning age (21-days-old ...
-
bioRxiv - Microbiology 2023Quote: ... and recombinant mouse IL-3 (10 ng/mL; R&D Systems, Cat. No. 403-ML). Cells were plated at a density of 1 × 106 cells/mL in a T-75 cm2 flask ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 20 ng/mL IL-3 and 20 ng/mL SCF (R&D Systems), 2% FBS ...
-
bioRxiv - Cell Biology 2023Quote: Primary antibodies used for immunofluorescent staining were: active caspase-3 (Rabbit, R&D Systems, AF835); laminin alpha3 chain (Mouse ...
-
bioRxiv - Cell Biology 2022Quote: ... then plated into T175 flasks with Interleukin-3 (IL3, R&D Systems, 203-IL-050) and macrophage colony-stimulating factor (M-CSF ...
-
bioRxiv - Genomics 2024Quote: ... and 1 ng/mL recombinant human interleukin IL-3 (R&D systems, 203-IL/CF). Phase 2 includes phase 1 media without IL-3 and phase 3 includes phase 1 media without IL-3 and SCF with holo-transferrin increased to 1 mg/mL final concentration ...
-
bioRxiv - Cell Biology 2020Quote: ... and BMP4-Lif (10 ng/mL of mouse BMP-4 R&D Systems,Inc. ...
-
bioRxiv - Genomics 2020Quote: ... 4 μg normal rabbit IgG (R&D Systems, AB-105-C, lot: ER1212071) and ChIP-grade protein G magnetic beads (Cell Signalling 9006S ...
-
bioRxiv - Immunology 2022Quote: ... 30 μg/mL LPS plus 25 ng/mL IL-4 (R&D Systems); or 5 μg/mL LPS ...
-
bioRxiv - Cell Biology 2022Quote: ... and human bone morphogenetic protein 4 (hBMP4, 1.5 ng/ml; R&D Systems) together with human vascular endothelial growth factor (hVEGF ...
-
bioRxiv - Neuroscience 2022Quote: ... 25 µg/ml human recombinant Bone Morphogenetic Protein 4 (BMP4, R&D Systems) and 55 µM β-mercaptoethanol (Life technologies) ...
-
bioRxiv - Cancer Biology 2020Quote: ... fibroblasts were treated for 4 days with recombinant human OSM (R&D Systems) at 10 ng/μl or vehicle (PBS ...
-
bioRxiv - Neuroscience 2020Quote: ... Antibodies used to assess pluripotency were anti-OCT3/4 (R&D Systems AF1759), anti-SOX2 (BD 245619) ...
-
bioRxiv - Immunology 2022Quote: ... or 4 μg/mL of anti-CCL1 Ab (clone 148113; R&D Systems), was added to the cultures.
-
bioRxiv - Immunology 2022Quote: ... 4 μg/mL of anti-CCL5 Ab (polyclonal goat IgG; R&D Systems), or 4 μg/mL of anti-CCL1 Ab (clone 148113 ...
-
bioRxiv - Cell Biology 2024Quote: ... 15 ng/mL BMP-4 (314-BP-050/CF; R&D Systems Inc) and 125 ng/mL Fibroblast growth factor (FGF ...
-
bioRxiv - Bioengineering 2024Quote: ... 1 ng/mL human bone morphogenetic protein 4 (Bmp4) (R&D Systems, Inc.), 20 ng/mL human basic fibroblast growth factor (b-FGF ...
-
bioRxiv - Cancer Biology 2023Quote: ... and recombinant human TIM-4-HIS (R&D Systems, Cat# 9407-TM-050)) ...
-
bioRxiv - Bioengineering 2023Quote: ... at 4°C for 16 h and measured via ELISA (R&D Systems). The distribution of TGF-β in Ø2×2 mm and Ø5×2 mm constructs was predicted via FE model (FEBio ...
-
bioRxiv - Immunology 2023Quote: ... and 10 ng/mL of IL-4 (R&D systems, 402-ML-020)) ...